Connor, Clark & Lunn Investment Management (CC&L)’s Calithera Biosciences, Inc CALA Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio CALA Stock Details CALA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-1,955	Closed	-$174K	–	1224
2020 Q1	$174K	Sell	1,955 -353	-15%	-$42.1K	﹤0.01%	882
2019 Q4	$264K	Buy	2,308 +825	+56%	+$62K	﹤0.01%	788
2019 Q3	$92K	Buy	1,483 +680	+85%	+$54.4K	﹤0.01%	914
2019 Q2	$63K	Buy	+803	New	+$91.1K	﹤0.01%	963
2017 Q4	–	Sell	-581	Closed	-$183K	–	881
2017 Q3	$183K	Buy	+581	New	+$183K	﹤0.01%	762
2017 Q1	–	Sell	-510	Closed	-$33K	–	1041
2016 Q4	$33K	Sell	510 -200	-28%	-$12.5K	﹤0.01%	864
2016 Q3	$46K	Buy	710 +185	+35%	+$11.9K	﹤0.01%	803
2016 Q2	$39K	Sell	525 -110	-17%	-$11K	﹤0.01%	840
2016 Q1	$72K	Sell	635 -160	-20%	-$18.1K	﹤0.01%	781
2015 Q4	$122K	Buy	+795	New	+$119K	﹤0.01%	743

Other funds holding CALA

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

MWNA

Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s CALA Position: Q2 2020 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of Calithera Biosciences, Inc (CALA) in Q2 2020, closing a stake of 1,955 shares — an estimated $174K sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in CALA in Q4 2015 and held it in 10 quarters. The position peaked at $264K in Q4 2019. 110 funds tracked by Wall St. Rank hold CALA as of Q2 2020.

Connor, Clark & Lunn Investment Management (CC&L) reported no remaining Calithera Biosciences, Inc position as of Q2 2020 after selling out during the quarter.
Connor, Clark & Lunn Investment Management (CC&L) sold 1,955 Calithera Biosciences, Inc shares in Q2 2020, an estimated $174K.
Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Calithera Biosciences, Inc in Q4 2015 and held it in 10 quarters.
Connor, Clark & Lunn Investment Management (CC&L)'s Calithera Biosciences, Inc position peaked at $264K in Q4 2019.
110 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q2 2020.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q2 2020, filed 13 Aug 2020.